Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
February-2020 Volume 12 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2020 Volume 12 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report Open Access

A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report

  • Authors:
    • Kien Trung Tran
    • Vinh Sy Le
    • Chinh Duy Vu
    • Liem Thanh Nguyen
  • View Affiliations / Copyright

    Affiliations: Vinmec Research Institute of Stem Cell and Gene Technology, Vinmec International Hospital, Hanoi 100000, Vietnam, Vinmec Times City International Hospital, Vinmec International Hospital, Hanoi 100000, Vietnam
    Copyright: © Tran et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 46-50
    |
    Published online on: November 27, 2019
       https://doi.org/10.3892/br.2019.1260
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Merosin deficient congenital muscular dystrophy type 1A (MDC1A) is caused by defects in the LAMA2 gene. Patients with MDC1A exhibit severe symptoms, including congenital hypotonia, delayed motor development and contractures. The present case report describes a Vietnamese male child with clinical manifestations of delayed motor development, limb‑girdle muscular dystrophy, severe scoliosis and white matter abnormality in the brain. Whole exome sequencing (WES) was performed with subsequent validation using Sanger sequencing, and a de novo missense variant (NM_000426.3:c.1964T>C, p.Leu655Pro) and a splice site variant (NG_008678.1:c.3556‑13T>A) in the LAMA2 gene of the proband was detected. The missense variant located in exon 14 and has not been reported previously, to the best of our knowledge; whereas the splice site variant has been previously reported to cause premature termination of transcription in patients with MDC1A. In silico tools predicted that the missense variant was damaging. Phenotype‑genotype analysis suggested that this proband was associated with classical early onset MDC1A. The co‑existence of a de novo and a heterozygous variant in the LAMA2 gene suggested that the de novo variant contributed to the autosomal recessive manner of the disease. Careful consideration of this event by clinical confirmation of parental carrier status may help to accurately determine the risk of occurrence of this disease in future offspring. Additionally, WES is recommended as a powerful tool to assist in identifying potentially causative variants for heterogeneous diseases such as MDC1A.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Durbeej M: Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment. Curr Top Membr. 76:31–60. 2015.PubMed/NCBI View Article : Google Scholar

2 

Allamand V and Guicheney P: Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for α2 chain of laminin). Eur J Hum Genet. 10:91–94. 2002.PubMed/NCBI View Article : Google Scholar

3 

Philpot J, Sewry C, Pennock J and Dubowitz V: Clinical phenotype in congenital muscular dystrophy: Correlation with expression of merosin in skeletal muscle. Neuromuscul Disord. 5:301–305. 1995.PubMed/NCBI View Article : Google Scholar

4 

Colognato H and Yurchenco PD: Form and function: The laminin family of heterotrimers. Dev Dyn. 218:213–234. 2000.PubMed/NCBI View Article : Google Scholar

5 

Holmberg J and Durbeej M: Laminin-211 in skeletal muscle function. Cell Adhes Migr. 7:111–121. 2013.PubMed/NCBI View Article : Google Scholar

6 

Xiong H, Tan D, Wang S, Song S, Yang H, Gao K, Liu A, Jiao H, Mao B, Ding J, et al: Genotype/phenotype analysis in Chinese laminin-α2 deficient congenital muscular dystrophy patients. Clin Genet. 87:233–243. 2015.PubMed/NCBI View Article : Google Scholar

7 

Oliveira J, Gruber A, Cardoso M, Taipa R, Fineza I, Gonçalves A, Laner A, Winder TL, Schroeder J, Rath J, et al: LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes. Hum Mutat. 39:1314–1337. 2018.PubMed/NCBI View Article : Google Scholar

8 

Zhou J, Tan J, Ma D, Zhang J, Cheng J, Luo C, Liu G, Wang Y and Xu Z: Identification of Two Novel LAMA2 Mutations in a Chinese Patient with Congenital Muscular Dystrophy. Front Genet. 9(43)2018.PubMed/NCBI View Article : Google Scholar

9 

Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y, Levy S, Gogos JA and Karayiorgou M: De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet. 44:1365–1369. 2012.PubMed/NCBI View Article : Google Scholar

10 

Yu M, Zheng Y, Jin S, Gang Q, Wang Q, Yu P, Lv H, Zhang W, Yuan Y and Wang Z: Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing. PLoS One. 12(e0175343)2017.PubMed/NCBI View Article : Google Scholar

11 

Chae JH, Lee JS, Hwang H, Kim KJ, Hwang YS, Park JD, Cheon JE, Kim IO, Choe GY and Park SH: Merosin-deficient congenital muscular dystrophy in Korea. Brain Dev. 31:341–346. 2009.PubMed/NCBI View Article : Google Scholar

12 

Dubowitz V, Oldfors A and Sewry C: Muscle Biopsy: A Practical Approach. 4th edition. Saunders Elsevier. 2013.

13 

Fischer AH, Jacobson KA, Rose J and Zeller R: Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008(pdb.prot4986)2008.PubMed/NCBI View Article : Google Scholar

14 

Li H and Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25:1754–1760. 2009.PubMed/NCBI View Article : Google Scholar

15 

Rimmer A, Phan H, Mathieson I, Iqbal Z, Twigg SRF, Wilkie AOM, McVean G and Lunter G: WGS500 Consortium: Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat Genet. 46:912–918. 2014.PubMed/NCBI View Article : Google Scholar

16 

DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al: A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 43:491–498. 2011.PubMed/NCBI View Article : Google Scholar

17 

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al: The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20:1297–1303. 2010.PubMed/NCBI View Article : Google Scholar

18 

Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA and Abecasis GR: 1000 Genomes Project Consortium: A global reference for human genetic variation. Nature. 526:68–74. 2015.PubMed/NCBI View Article : Google Scholar

19 

Cingolani P, Platts A, Wang L, Coon M, Nguyen T, Wang L, Land SJ, Lu X and Ruden DM: A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 6:80–92. 2012.PubMed/NCBI View Article : Google Scholar

20 

Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M and Cooper DN: Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat. 21:577–581. 2003.PubMed/NCBI View Article : Google Scholar

21 

Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods. 7:248–249. 2010.PubMed/NCBI View Article : Google Scholar

22 

Choi Y and Chan AP: PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 31:2745–2747. 2015.PubMed/NCBI View Article : Google Scholar

23 

Venselaar H, Te Beek TAH, Kuipers RKP, Hekkelman ML and Vriend G: Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 11(548)2010.PubMed/NCBI View Article : Google Scholar

24 

Paganoni S and Amato A: Electrodiagnostic evaluation of myopathies. Phys Med Rehabil Clin N Am. 24:193–207. 2013.PubMed/NCBI View Article : Google Scholar

25 

Palisano R, Rosenbaum P, Walter S, Russell D, Wood E and Galuppi B: Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 39:214–223. 1997.PubMed/NCBI View Article : Google Scholar

26 

Hanna SE, Bartlett DJ, Rivard LM and Russell DJ: Reference curves for the Gross Motor Function Measure: Percentiles for clinical description and tracking over time among children with cerebral palsy. Phys Ther. 88:596–607. 2008.PubMed/NCBI View Article : Google Scholar

27 

Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S and Jarvis S: The gross motor function measure: A means to evaluate the effects of physical therapy. Dev Med Child Neurol. 31:341–352. 1989.PubMed/NCBI View Article : Google Scholar

28 

Bohannon RW and Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 67:206–207. 1987.PubMed/NCBI View Article : Google Scholar

29 

Ewing B and Green P: Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 8:186–194. 1998.PubMed/NCBI View Article : Google Scholar

30 

Le VS, Tran KT, Bui HTP, Le HTT Nguyen CD, Do DH, Ly HTT, Pham LTD, Dao LTM and Nguyen LT: A Vietnamese human genetic variation database. Hum Mutat. 40:1664–1675. 2019.PubMed/NCBI View Article : Google Scholar

31 

Hayashi YK, Tezak Z, Momoi T, Nonaka I, Garcia CA, Hoffman EP and Arahata K: Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy. Neuromuscul Disord. 11:350–359. 2001.PubMed/NCBI View Article : Google Scholar

32 

Sparks SE and Escolar DM: Congenital muscular dystrophies. In: Handbook of Clinical Neurology. Griggs RC and Amato AA (eds). Vol 101. Elsevier. pp47–79. 2011.

33 

Canki-Klain N, Béroud C, Clarke NF, Kovac I, Chambert S and Guicheney P: EM.P.3.01 The adult phenotype of congenital muscular dystrophy (MDC1A) due to mutation of LAMA2. Neuromuscul Disord. 19(574)2009. View Article : Google Scholar

34 

Jones KJ, Morgan G, Johnston H, Tobias V, Ouvrier RA, Wilkinson I and North KN: The expanding phenotype of laminin α2 chain (merosin) abnormalities: Case series and review. J Med Genet. 38:649–657. 2001.PubMed/NCBI View Article : Google Scholar

35 

Reddy HM, Cho KA, Lek M, Estrella E, Valkanas E, Jones MD, Mitsuhashi S, Darras BT, Amato AA, Lidov HG, et al: The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States. J Hum Genet. 62:243–252. 2017.PubMed/NCBI View Article : Google Scholar

36 

Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, Vertino-Bell A, Smaoui N, Neidich J, Monaghan KG, et al: Clinical application of whole-exome sequencing across clinical indications. Genet Med. 18:696–704. 2016.PubMed/NCBI View Article : Google Scholar

37 

Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, et al: Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 312:1870–1879. 2014.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tran KT, Le VS, Vu CD and Nguyen LT: A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report. Biomed Rep 12: 46-50, 2020.
APA
Tran, K.T., Le, V.S., Vu, C.D., & Nguyen, L.T. (2020). A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report. Biomedical Reports, 12, 46-50. https://doi.org/10.3892/br.2019.1260
MLA
Tran, K. T., Le, V. S., Vu, C. D., Nguyen, L. T."A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report". Biomedical Reports 12.2 (2020): 46-50.
Chicago
Tran, K. T., Le, V. S., Vu, C. D., Nguyen, L. T."A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report". Biomedical Reports 12, no. 2 (2020): 46-50. https://doi.org/10.3892/br.2019.1260
Copy and paste a formatted citation
x
Spandidos Publications style
Tran KT, Le VS, Vu CD and Nguyen LT: A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report. Biomed Rep 12: 46-50, 2020.
APA
Tran, K.T., Le, V.S., Vu, C.D., & Nguyen, L.T. (2020). A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report. Biomedical Reports, 12, 46-50. https://doi.org/10.3892/br.2019.1260
MLA
Tran, K. T., Le, V. S., Vu, C. D., Nguyen, L. T."A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report". Biomedical Reports 12.2 (2020): 46-50.
Chicago
Tran, K. T., Le, V. S., Vu, C. D., Nguyen, L. T."A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report". Biomedical Reports 12, no. 2 (2020): 46-50. https://doi.org/10.3892/br.2019.1260
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team